These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6117899)

  • 1. Prostacyclin and vascular disease.
    Gryglewski RJ; Szczeklik A; Zygulska-Mach H; Kostka-Trabka E
    Philos Trans R Soc Lond B Biol Sci; 1981 Aug; 294(1072):383-8. PubMed ID: 6117899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prostacyclin (PGX, PGI2)-vascular anti-aggregation hormone regulating hemostasis].
    Feldman R
    Pol Arch Med Wewn; 1980 Jul; 64(1):57-67. PubMed ID: 6999470
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostacyclin analogues as antiatherosclerotic drugs.
    Orekhov AN; Tertov VV; Smirnov VN
    Lancet; 1983 Aug; 2(8348):521. PubMed ID: 6136682
    [No Abstract]   [Full Text] [Related]  

  • 4. Prostaglandins, prostacyclin and arteries.
    Szczeklik A
    Adv Nephrol Necker Hosp; 1981; 10():27-36. PubMed ID: 6791472
    [No Abstract]   [Full Text] [Related]  

  • 5. Low density lipoproteins (LDL) are carriers for lipid peroxides and inhibit prostacyclin (PGI2) biosynthesis in arteries.
    Szczeklik A; Gryglewski RJ
    Artery; 1980; 7(6):488-95. PubMed ID: 7016082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of prostacyclin (PGI2) on retinal arteries].
    Zygulska-Machowa H; Kostka-Trabkowa E; Nitoń A; Dembińska-Kieciowa A; Kedzior A; Basista M; Gryglewski RJ
    Klin Oczna; 1984 Apr; 86(4):149-51. PubMed ID: 6381868
    [No Abstract]   [Full Text] [Related]  

  • 7. Prostacyclin and atherosclerosis.
    Szczeklik A
    Triangle; 1980; 19(2):61-7. PubMed ID: 7003851
    [No Abstract]   [Full Text] [Related]  

  • 8. [Vascular endothelium in the processes of hemostasis and thrombosis. The role of prostacyclin and EDRF].
    Radomski MW
    Acta Physiol Pol; 1989; 40 Suppl 33():97-109. PubMed ID: 2489269
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pathogenetic importance of prostacyclin in atherosclerosis].
    Efimov VV; Ladnyĭ AI
    Ter Arkh; 1985; 57(9):142-8. PubMed ID: 3909478
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prostacyclins and the development and treatment of arteriosclerosis].
    Szczeklik A
    Kardiol Pol; 1980; 23(7):537-46. PubMed ID: 6999208
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of prostacyclin on glycemia and insulin release in man.
    Szczeklik A; Pietoń R; Sieradzki J; Nizankowski R
    Prostaglandins; 1980 Jun; 19(6):959-68. PubMed ID: 6104347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostacyclin and blood coagulation.
    Moncada S; Vane JR
    Drugs; 1981 Jun; 21(6):430-7. PubMed ID: 7018874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trials of PGE1, PGI2 and mimetics in patients with peripheral vascular disease.
    Sinzinger H; Virgolini I; O'Grady J
    Prog Clin Biol Res; 1989; 301():85-96. PubMed ID: 2477859
    [No Abstract]   [Full Text] [Related]  

  • 14. [Lipid peroxide metabolism and PGI2/TXA2 balance in hyperlipidemic rabbits: a study on the anti-atherosclerotic effects of Rhapoticum uniflorum DC].
    Wang J
    Zhonghua Yi Xue Za Zhi; 1987 May; 67(5):276-9. PubMed ID: 3115528
    [No Abstract]   [Full Text] [Related]  

  • 15. A possible role of thromboxane A2 (TXA2) and prostacyclin (PGI2) in circulation.
    Gryglewski RJ; Dembínska-Kieć A; Korbut R
    Acta Biol Med Ger; 1978; 37(5-6):715-23. PubMed ID: 369254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostacyclin (PGI2).
    Davies SC; Machin SJ
    Intensive Care Med; 1983; 9(2):49-52. PubMed ID: 6343445
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostacyclin--experimental and clinical approach.
    Gryglewski R
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():457-61. PubMed ID: 6221563
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prostaglandins and arteriosclerosis. Action of PGI 2 (PGX) on platelet aggregation].
    Messini M; Messini F
    Clin Ter; 1979 Jul; 90(1):3-9. PubMed ID: 394908
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prospects of antiaggregant therapy in prevention of atherosclerosis].
    Strano A; Novo S
    G Ital Cardiol; 1979; 9(1):5-9. PubMed ID: 396163
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of prostaglandin I2 (PGI2) formation by LDL-cholesterol or LDL-peroxides?
    Beitz J; Panse M; Fischer S; Hora C; Förster W
    Prostaglandins; 1983 Dec; 26(6):885-92. PubMed ID: 6396733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.